Get the Stockscreener App
0.317
3.27%
-0.0107
After Hours:
.32
0.003
+0.95%
Bioaffinity Technologies Inc stock is traded at $0.317, with a volume of 355.87K.
It is down -3.27% in the last 24 hours and up +10.38% over the past month.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
See More
Previous Close:
$0.3277
Open:
$0.35
24h Volume:
355.87K
Relative Volume:
0.05
Market Cap:
$9.02M
Revenue:
$9.37M
Net Income/Loss:
$-8.45M
P/E Ratio:
-0.3914
EPS:
-0.81
Net Cash Flow:
$-7.27M
1W Performance:
-8.67%
1M Performance:
+10.38%
6M Performance:
-58.28%
1Y Performance:
-87.27%
1-Day Range:
$0.3081
$0.35
1-Week Range:
$0.3081
$0.3627
52-Week Range:
$0.1639
$2.4796
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Name
Bioaffinity Technologies Inc
Sector
Industry
Phone
210-698-5334
Address
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.317 | 9.33M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
467.68 | 180.17B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.16 | 146.07B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
534.31 | 46.01B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.81 | 33.53B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
185.86 | 32.56B | 15.50B | 1.33B | 2.16B | 7.34 |
Bioaffinity Technologies Inc Stock (BIAF) Latest News
bioAffinity’s CyPath® Lung Test Detects Early Cancer - TipRanks
Annaly Capital to Issue Series J Preferred; Redeemable 2030 | BIAFW SEC FilingForm 8-K - Stock Titan
Is bioAffinity Technologies Inc. Equity Warrant stock overvalued or undervaluedRetirement Planning Entry Points For Every Investor - jammulinksnews.com
Building trade automation scripts for bioAffinity Technologies Inc.Optimized Watchlist With Daily Adjustments Launched - metal.it
What are bioAffinity Technologies Inc. company’s key revenue driversLow Risk Alerts With Proven Results - jammulinksnews.com
How Resilient Is bioAffinity Technologies Inc. Stock During Economic DownturnsWeekly Stock Opportunity Radar Scanner Activated - metal.it
Revolutionary CyPath Lung Test Catches Hidden Cancer After Standard Tests Failed: Critical Case Study Reveals - Stock Titan
Published on: 2025-07-28 23:30:16 - metal.it
bioAffinity Technologies Inc. Pullback Analyzed — Is It Time to ExitCommunity Entry Consensus Trade Ideas Shared - metal.it
Is bioAffinity Technologies Inc. Equity Warrant a growth stock or a value stockExpert Picks Tracker For Beginners - jammulinksnews.com
What are bioAffinity Technologies Inc. Equity Warrant company’s key revenue driversTop Growth Entry Points For Every Investor - jammulinksnews.com
What is the dividend policy of bioAffinity Technologies Inc. stockHigh-margin investment plays - jammulinksnews.com
How strong is bioAffinity Technologies Inc. Equity Warrant company’s balance sheetFree Stock Chart Pattern Guide - jammulinksnews.com
How many analysts rate bioAffinity Technologies Inc. Equity Warrant as a “Buy”Identify winners with top-tier analysis - jammulinksnews.com
Technical Models Detect Momentum Build in bioAffinity Technologies Inc. Equity WarrantTarget Return Focused Trade Insights Shared - metal.it
Is bioAffinity Technologies Inc. stock entering bullish territory Free Smart Trend Trading with Weekly Signals - metal.it
What institutional investors are buying bioAffinity Technologies Inc. Equity Warrant stockHigh-profit trading signals - jammulinksnews.com
Is bioAffinity Technologies Inc. a growth stock or a value stockInvest confidently with professional market insights - jammulinksnews.com
What is the risk reward ratio of investing in bioAffinity Technologies Inc. stockCapitalize on market trends before they peak - jammulinksnews.com
What is bioAffinity Technologies Inc. company’s growth strategyInvest confidently with real-time data analysis - jammulinksnews.com
Is it the right time to buy bioAffinity Technologies Inc. Equity Warrant stockTurn market volatility into profit opportunities - jammulinksnews.com
What catalysts could drive bioAffinity Technologies Inc. stock higher in 2025Invest smarter with expert stock recommendations - jammulinksnews.com
What is the risk reward ratio of investing in bioAffinity Technologies Inc. Equity Warrant stockFree Trading Psychology Coaching - jammulinksnews.com
What is the dividend policy of bioAffinity Technologies Inc. Equity Warrant stockInvest confidently with data-driven strategies - jammulinksnews.com
Published on: 2025-07-28 05:02:09 - jammulinksnews.com
What are the technical indicators suggesting about bioAffinity Technologies Inc. Equity WarrantUncover the best stocks for explosive growth - jammulinksnews.com
What are the latest earnings results for bioAffinity Technologies Inc.Free Advanced Stock Screener Access - jammulinksnews.com
Should I hold or sell bioAffinity Technologies Inc. Equity Warrant stock in 2025Free Market Dynamics Reports - jammulinksnews.com
Why is bioAffinity Technologies Inc. stock attracting strong analyst attentionAccelerated wealth expansion - jammulinksnews.com
Published on: 2025-07-27 17:42:07 - jammulinksnews.com
What are the latest earnings results for bioAffinity Technologies Inc. Equity WarrantSpectacular growth rates - jammulinksnews.com
bioAffinity Technologies Approves Key Proposals Amidst Financial Challenges - AInvest
bioAffinity Technologies (NASDAQ:BIAF) Stock Price Down 3.8% – Time to Sell? - Defense World
What analysts say about bioAffinity Technologies Inc. stockExtraordinary profit generation - PrintWeekIndia
What analysts say about bioAffinity Technologies Inc. Equity Warrant stockSuperior profit margins - PrintWeekIndia
bioAffinity Technologies Approves Key Proposals at Annual Meeting - TipRanks
Is bioAffinity Technologies Inc. Equity Warrant stock a good hedge against inflationHigh-velocity capital appreciation - jammulinksnews.com
bioAffinity Technologies Inc. Stock Analysis and ForecastLightning-fast growth - PrintWeekIndia
What institutions are buying bioAffinity Technologies Inc. stock nowConsistent triple returns - jammulinksnews.com
When is the best time to buy bioAffinity Technologies Inc. Equity Warrant stockMarket-beating returns - jammulinksnews.com
Will bioAffinity Technologies Inc. stock benefit from interest rate changesSkyrocketing investment returns - jammulinksnews.com
What drives bioAffinity Technologies Inc. stock priceDynamic growth stocks - Autocar Professional
bioAffinity Technologies Inc. Equity Warrant Stock Analysis and ForecastSuperior investment outcomes - jammulinksnews.com
bioAffinity’s CyPath® Lung Test Identifies Missed Tumor - TipRanks
Breakthrough: New Lung Cancer Test Catches Hidden Stage 1A Tumor Other Diagnostics Missed - Stock Titan
The BIAF Stock Puzzle: Unraveling BioAffinity Technologies Inc’s Fluctuating Performance - investchronicle.com
Bioaffinity Technologies Inc Stock (BIAF) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):